PERRY A. KARSEN

Insider Reports History

Location
Summit, NJ
Signature
/s/ Zed Zduniak, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PERRY A. KARSEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Graphite Bio, Inc. Director Stock Option (right to buy) 20,000 19 Jul 2023 Direct
Jounce Therapeutics, Inc. Director Common Stock 0 $1.85 03 May 2023 Direct
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 0 03 May 2023 Direct

Insider Reports Filed by PERRY A. KARSEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LENZ Graphite Bio, Inc. 19 Jul 2023 1 $0 4 Director 21 Jul 2023, 17:10
/report/000164045523000111-karsen-perry-a-2023-05-03 Jounce Therapeutics, Inc. 03 May 2023 8 $0 4 Director 04 May 2023, 07:44
/report/000164045522000073-karsen-perry-a-2022-06-24 Jounce Therapeutics, Inc. 24 Jun 2022 1 $0 4 Director 28 Jun 2022, 21:07
LENZ Graphite Bio, Inc. 21 Jun 2022 1 $0 4 Director 22 Jun 2022, 17:38
LENZ Graphite Bio, Inc. 24 Jun 2021 0 $0 3 Director 24 Jun 2021, 21:14
/report/000164045521000108-karsen-perry-a-2021-06-18 Jounce Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 16:34
LENZ Graphite Bio, Inc. 13 Jan 2021 5 +$100,001 4 Director 01 Jul 2021, 19:00